Pluronic L-81 ameliorates diabetic symptoms in db/db mice through transcriptional regulation of microsomal triglyceride transfer protein

World Journal of Gastroenterology

Volumn 15, Issue 24, 2009, Pages 2987-2994

  Au, Wo Shing ^a   Lu, Li Wei ^b   Tam, Sidney ^c   Ko, Otis King Hung ^b   Chow, Billy K C ^b   He, Ming Liang ^d   Ng, Samuel S ^a   Yeung, Chung Man ^a   Liu, Ching Chiu ^a   Kung, Hsiang Fu ^d   Lin, Marie C ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c QUEEN MARY HOSPITAL   (Hong Kong)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Animal models; db db mice; Diabetes; Microsomal triglyceride protein; Pluronic L 81

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; GLUCOSE; MESSENGER RNA; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; POLOXAMER; ROSIGLITAZONE; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CELL CULTURE; CELL STRAIN HEPG2; CELL VOLUME; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERPHAGIA; LIPID BLOOD LEVEL; LIVER TOXICITY; MALE; MOLECULAR MECHANICS; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; POLYDIPSIA; PROTEIN SECRETION; TRANSCRIPTION REGULATION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 67651245168     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.2987     Document Type: Article

References (33)

1. Schmolka IR. A review of block polymer surfactants. J Am Oil Chem 1977; 54: 110-116
2. O'Driscoll CM. Lipid-based formulations for intestinal lymphatic delivery. Eur J Pharm Sci 2002; 15: 405-415
3. Kabanov AV, Batrakova EV, Alakhov VY. Pluronic block copolymers for overcoming drug resistance in cancer. Adv Drug Deliv Rev 2002; 54: 759-779
4. Tso P, Balint JA, Rodgers JB. Effect of hydrophobic surfactant (Pluronic L-81) on lymphatic lipid transport in the rat. Am J Physiol 1980; 239: G348-G353
5. Tso P, Drake DS, Black DD, Sabesin SM. Evidence for separate pathways of chylomicron and very low-density lipoprotein assembly and transport by rat small intestine. Am J Physiol 1984; 247: G599-G610
6. Manowitz NR, Tso P, Drake DS, Frase S, Sabesin SM. Dietary supplementation with Pluronic L-81 modifies hepatic secretion of very low density lipoproteins in the rat. J Lipid Res 1986; 27: 196-207
7. Fatma S, Yakubov R, Anwar K, Hussain MM. Pluronic L81 enhances triacylglycerol accumulation in the cytosol and inhibits chylomicron secretion. J Lipid Res 2006; 47: 2422-2432
8. Brunelle CW, Bochenek WJ, Abraham R, Kim DN, Rodgers JB. Effect of hydrophobic detergent on lipid absorption in the rat and on lipid and sterol balance in the swine. Dig Dis Sci 1979; 24: 718-725
9. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA 1999; 282: 1523-1529
10. Marx J. Unraveling the causes of diabetes. Science 2002; 296: 686-689
11. Field AE, Coakley EH, Must A, Spadano JL, Laird N, Dietz WH, Rimm E, Colditz GA. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med 2001; 161: 1581-1586
12. Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995; 122: 481-486
13. Flier JS. Obesity wars: molecular progress confronts an expanding epidemic. Cell 2004; 116: 337-350
14. Kobayashi K, Forte TM, Taniguchi S, Ishida BY, Oka K, Chanb L. The db/db mouse, a model for diabetic dyslipidemia: molecular characterization and effects of Western diet feeding. Metabolism 2000; 49: 22-31
15. Lin MC, Gordon D, Wetterau JR. Microsomal triglyceride transfer protein (MTP) regulation in HepG2 cells: insulin negatively regulates MTP gene expression. J Lipid Res 1995; 36: 1073-1081
16. Au WS, Kung HF, Lin MC. Regulation of microsomal triglyceride transfer protein gene by insulin in HepG2 cells: roles of MAPKerk and MAPKp38. Diabetes 2003; 52: 1073-1080
17. Lee CH, Olson P, Evans RM. Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology 2003; 144: 2201-2207
18. Burnett JR, Watts GF. MTP inhibition as a treatment for dyslipidaemias: time to deliver or empty promises? Expert Opin Ther Targets 2007; 11: 181-189
19. Arner P. The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones. Trends Endocrinol Metab 2003; 14: 137-145
20. Moller DE. New drug targets for type 2 diabetes and the metabolic syndrome. Nature 2001; 414: 821-827
21. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229-234
22. Bak JF, Moller N, Schmitz O, Saaek A, Pedersen O. In vivo insulin action and muscle glycogen synthase activity in type 2 (non-insulin-dependent) diabetes mellitus: effects of diet treatment. Diabetologia 1992; 35: 777-784
23. Cancello R, Tounian A, Poitou Ch, Clement K. Adiposity signals, genetic and body weight regulation in humans. Diabetes Metab 2004; 30: 215-227
24. Freidenberg GR, Reichart D, Olefsky JM, Henry RR. Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellitus. Effect of weight loss. J Clin Invest 1988; 82: 1398-1406
25. Rodgers JB, Kyriakides EC, Kapuscinska B, Peng SK, Bochenek WJ. Hydrophobic surfactant treatment prevents atherosclerosis in the rabbit. J Clin Invest 1983; 71: 1490-1494
26. Chaput E, Saladin R, Silvestre M, Edgar AD. Fenofibrate and rosiglitazone lower serum triglycerides with opposing effects on body weight. Biochem Biophys Res Commun 2000; 271: 445-450
27. Mukherjee R, Hoener PA, Jow L, Bilakovics J, Klausing K, Mais DE, Faulkner A, Croston GE, Paterniti JR Jr. A selective peroxisome proliferator-activated receptor-gamma (PPARgamma) modulator blocks adipocyte differentiation but stimulates glucose uptake in 3T3-L1 adipocytes. Mol Endocrinol 2000; 14: 1425-1433
28. Pidlich J, Renner F, Ellinger A, Huttinger M, Pavelka M, Gangl A. Effect of pluronic L-81 on intestinal lipoprotein secretion in the rat. Dig Dis Sci 1996; 41: 1445-1451
29. Tso P, Balint JA, Bishop MB, Rodgers JB. Acute inhibition of intestinal lipid transport by Pluronic L-81 in the rat. Am J Physiol 1981; 241: G487-G497
30. Nutting DF, Tso P. Hypolipidemic effect of intravenous pluronic L-81 in fasted rats treated with Triton WR-1339: possible inhibition of hepatic lipoprotein secretion. Horm Metab Res 1989; 21: 113-115
31. Wetterau JR, Lin MC, Jamil H. Microsomal triglyceride transfer protein. Biochim Biophys Acta 1997; 1345: 136-150
32. Au WS, Lu L, Yeung CM, Liu CC, Wong OG, Lai L, Kung HF, Lin MC. Hepatocyte nuclear factor 1 binding element within the promoter of microsomal triglyceride transfer protein (MTTP) gene is crucial for MTTP basal expression and insulin responsiveness. J Mol Endocrinol 2008; 41: 229-238
33. Odom DT, Zizlsperger N, Gordon DB, Bell GW, Rinaldi NJ, Murray HL, Volkert TL, Schreiber J, Rolfe PA, Gifford DK, Fraenkel E, Bell GI, Young RA. Control of pancreas and liver gene expression by HNF transcription factors. Science 2004; 303: 1378-1381